Close

Amgen (AMGN) Tops Q1 EPS by 30c, Raises FY Guidance

April 28, 2016 4:03 PM EDT

Amgen (NASDAQ: AMGN) reported Q1 EPS of $2.90, $0.30 better than the analyst estimate of $2.60. Revenue for the quarter came in at $5.53 billion versus the consensus estimate of $5.32 billion.

GUIDANCE:

Amgen sees FY2016 EPS of $10.85-$11.20, versus prior guidance of $10.60-$11.00 and the consensus of $10.82.

For earnings history and earnings-related data on Amgen (AMGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings